ReviewDiscover nano2026
Research progress and prospects of nanomaterials in imaging of central nervous system diseases.
Review in Discover nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Nanomaterials have garnered significant attention in recent years for their application in the imaging of central nervous system diseases (CNSDs). To comprehensively understand the research progress and trends in this field, this paper conducted a bibliometric analysis of relevant literature over the past fourteen years, systematically reviewing the research hotspots and development trends in the application of nanomaterials for CNSDs imaging. Using CiteSpace for visual data analysis, relationship networks among countries, institutions, journals, research categories, authors, and keywords were presented through specified mapping. The findings reveal that China is the country with the highest number of publications, the Chinese Academy of Sciences is the institution with the most published articles, and "Biomaterials" is the most frequently cited journal. Keywords such as fluorescence imaging, release, proteins, and targeted delivery represent current research hotspots, indicating a shift in focus toward precision imaging and intelligent delivery. Cluster analysis reveals that current research has progressed from single-performance optimization to the development of intelligent responsive nano-systems-integrating targeted delivery, environmentally responsive release, and multimodal imaging. However, nanomaterials still face multiple challenges and limitations spanning from basic research to clinical translation, and their application in CNSDs remains experimental. Therefore, further interdisciplinary research across materials science, chemistry, biology, and medicine is necessary to break down disciplinary barriers and promote clinical translation, ultimately enabling revolutionary breakthroughs in nano-theranostic technologies for central nervous system diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.